U.S. flag

An official website of the United States government

NM_004168.4(SDHA):c.146A>G (p.Asp49Gly) AND multiple conditions

Germline classification:
Benign (1 submission)
Last evaluated:
Jan 31, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000228248.21

Allele description [Variation Report for NM_004168.4(SDHA):c.146A>G (p.Asp49Gly)]

NM_004168.4(SDHA):c.146A>G (p.Asp49Gly)

Gene:
SDHA:succinate dehydrogenase complex flavoprotein subunit A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5p15.33
Genomic location:
Preferred name:
NM_004168.4(SDHA):c.146A>G (p.Asp49Gly)
HGVS:
  • NC_000005.10:g.223564A>G
  • NG_012339.1:g.10324A>G
  • NM_001294332.2:c.146A>G
  • NM_001330758.2:c.146A>G
  • NM_004168.4:c.146A>GMANE SELECT
  • NP_001281261.1:p.Asp49Gly
  • NP_001317687.1:p.Asp49Gly
  • NP_004159.2:p.Asp49Gly
  • LRG_315t1:c.146A>G
  • LRG_315:g.10324A>G
  • LRG_315p1:p.Asp49Gly
  • NC_000005.9:g.223679A>G
  • NM_004168.2:c.146A>G
  • NM_004168.3:c.146A>G
  • p.D49G
Protein change:
D49G
Links:
dbSNP: rs80207011
NCBI 1000 Genomes Browser:
rs80207011
Molecular consequence:
  • NM_001294332.2:c.146A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330758.2:c.146A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004168.4:c.146A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Mitochondrial complex II deficiency, nuclear type 1
Synonyms:
Mitochondrial complex II deficiency; Complex 2 mitochondrial respiratory chain deficiency; Succinate CoQ reductase deficiency
Identifiers:
MONDO: MONDO:0100294; MedGen: C5700310; Orphanet: 3208; OMIM: 252011
Name:
Paragangliomas 5 (PPGL5)
Synonyms:
PHEOCHROMOCYTOMA/PARAGANGLIOMA SYNDROME 5
Identifiers:
MONDO: MONDO:0013602; MedGen: C3279992; Orphanet: 29072; OMIM: 614165

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000288113Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Benign
(Jan 31, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000288113.10

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024